Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA WOCKHARDT ALEMBIC PHARMA/
WOCKHARDT
 
P/E (TTM) x 32.2 -16.8 - View Chart
P/BV x 4.4 2.7 164.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 ALEMBIC PHARMA   WOCKHARDT
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
WOCKHARDT
Mar-23
ALEMBIC PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs792316 251.1%   
Low Rs463145 318.7%   
Sales per share (Unadj.) Rs287.6184.0 156.3%  
Earnings per share (Unadj.) Rs17.4-43.1 -40.4%  
Cash flow per share (Unadj.) Rs31.4-25.7 -122.3%  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.3231.7 96.0%  
Shares outstanding (eoy) m196.56144.09 136.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.3 174.3%   
Avg P/E ratio x36.1-5.3 -674.9%  
P/CF ratio (eoy) x20.0-9.0 -222.7%  
Price / Book Value ratio x2.81.0 283.9%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,40233,202 371.7%   
No. of employees `000NANA-   
Total wages/salary Rs m11,6916,370 183.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,52626,510 213.2%  
Other income Rs m301,220 2.5%   
Total revenues Rs m56,55727,730 204.0%   
Gross profit Rs m6,772-1,930 -350.9%  
Depreciation Rs m2,7542,510 109.7%   
Interest Rs m5023,020 16.6%   
Profit before tax Rs m3,546-6,240 -56.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126-30 -420.3%   
Profit after tax Rs m3,420-6,210 -55.1%  
Gross profit margin %12.0-7.3 -164.5%  
Effective tax rate %3.60.5 739.7%   
Net profit margin %6.1-23.4 -25.8%  
BALANCE SHEET DATA
Current assets Rs m29,13919,140 152.2%   
Current liabilities Rs m16,40834,350 47.8%   
Net working cap to sales %22.5-57.4 -39.3%  
Current ratio x1.80.6 318.7%  
Inventory Days Days1039 24.6%  
Debtors Days Days711 61.6%  
Net fixed assets Rs m31,49848,670 64.7%   
Share capital Rs m393720 54.6%   
"Free" reserves Rs m43,31232,660 132.6%   
Net worth Rs m43,70533,380 130.9%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m60,63770,750 85.7%  
Interest coverage x8.1-1.1 -756.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.4 248.8%   
Return on assets %6.5-4.5 -143.4%  
Return on equity %7.8-18.6 -42.1%  
Return on capital %9.3-9.0 -102.5%  
Exports to sales %46.40-   
Imports to sales %12.13.5 349.0%   
Exports (fob) Rs m26,210NA-   
Imports (cif) Rs m6,846920 744.1%   
Fx inflow Rs m26,210730 3,590.4%   
Fx outflow Rs m6,846920 744.1%   
Net fx Rs m19,364-190 -10,191.8%   
CASH FLOW
From Operations Rs m7,2401,530 473.2%  
From Investments Rs m-4,476-1,250 358.1%  
From Financial Activity Rs m-2,620-3,150 83.2%  
Net Cashflow Rs m144-2,800 -5.1%  

Share Holding

Indian Promoters % 69.1 54.9 125.8%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 4.5 424.6%  
FIIs % 4.5 4.2 108.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 45.1 67.4%  
Shareholders   85,212 161,813 52.7%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Wockhardt Share Price Performance

Period ALEMBIC PHARMA Wockhardt S&P BSE HEALTHCARE
1-Day -0.15% 4.99% 1.18%
1-Month -4.30% 0.15% -0.75%
1-Year 105.43% 290.07% 61.82%
3-Year CAGR 0.89% 13.79% 18.16%
5-Year CAGR 13.56% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.